Literature DB >> 4832517

Etiology, pathogenesis, and prevention of spinal cord lesions in selective angiography of the bronchial and intercostal arteries.

V Kardjiev, A Symeonov, I Chankov.   

Abstract

Mesh：

Substances：

Year:  1974        PMID： 4832517     DOI： 10.1148/112.1.81

Source DB:  PubMed          Journal:  Radiology        ISSN： 0033-8419            Impact factor:   11.105


× No keyword cloud information.
  8 in total

1.  Case of adults with cystic fibrosis has become an increasingly prominent part of the professional life of many respiratory physicians.

Authors:  D J Shale
Journal:  Thorax       Date:  1997-01       Impact factor: 9.139

2.  Extravasation of contrast medium during spinal angiography: a case of paraplegia.

Authors:  I F Moseley; B M Tress
Journal:  Neuroradiology       Date:  1977-03-28       Impact factor: 2.804

3.  Percutaneous embolotherapy in life-threatening hemoptysis.

Authors:  N M Hickey; R A Peterson; J A Leech; R J Chambers; F M Shamji
Journal:  Cardiovasc Intervent Radiol       Date:  1988-10       Impact factor: 2.740

Review 4.  Bronchial artery embolization to control hemoptysis: a review.

Authors:  J F Stoll; M A Bettmann
Journal:  Cardiovasc Intervent Radiol       Date:  1988-10       Impact factor: 2.740

5.  Bronchial artery embolization for treatment of life-threatening hemoptysis.

Authors:  January K Lopez; Hsin-Yi Lee
Journal:  Semin Intervent Radiol       Date:  2006-09       Impact factor: 1.513

6.  Bronchial artery infusion of mitomycin C in carcinoma of the lung.

Authors:  S Ekholm; U Albrechtsson; U Tylén
Journal:  Cardiovasc Intervent Radiol       Date:  1983       Impact factor: 2.740

7.  "Bronchial artery delivery of viral vectors for gene delivery in cystic fibrosis; superior to airway delivery?".

Authors:  Ameet Bakhai; Desmond J Sheridan; Charles C Coutelle
Journal:  BMC Pulm Med       Date:  2002-04-03       Impact factor: 3.317

8.  Outcomes of bronchial artery embolization for life-threatening hemoptysis secondary to tuberculosis.

Authors:  Renguang Pei; Yunfeng Zhou; Guoxiang Wang; Heping Wang; Xinyu Huang; Xiaoxing Yan; Xiaohua Yang
Journal:  PLoS One       Date:  2014-12-26       Impact factor: 3.240
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.